Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy

Wu, X., Scott, H., Carlsson, S.V. et al. (13 more authors) (2019) Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy. The Prostate, 79 (10). pp. 1079-1089. ISSN 0270-4137

Abstract

Metadata

Authors/Creators:
  • Wu, X.
  • Scott, H.
  • Carlsson, S.V.
  • Sjoberg, D.D.
  • Cerundolo, L.
  • Lilja, H.
  • Prevo, R.
  • Rieunier, G.
  • Macaulay, V.
  • Higgins, G.S.
  • Verrill, C.L.
  • Lamb, A.D.
  • Cunliffe, V.T. https://orcid.org/0000-0001-7483-7610
  • Bountra, C.
  • Hamdy, F.C.
  • Bryant, R.J.
Copyright, Publisher and Additional Information: © 2019 The Authors. The Prostate Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: enhancer of zeste 2; prostate cancer; radiotherapy
Dates:
  • Accepted: 12 April 2019
  • Published (online): 18 May 2019
  • Published: 1 July 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Biological Sciences (Sheffield) > Department of Biomedical Science (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 03 Jul 2019 08:36
Last Modified: 03 Jul 2019 12:06
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1002/pros.23817
Related URLs:

Share / Export

Statistics